Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
Open Access
- 25 March 2021
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 22 (1) , 1-10
Abstract
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent hereditary renal disease. There is an increased rate of cardiovascular disease (CVD) in ADPKD. In this study, we evaluate the prevalence of cardiovascular risk factors, the achievement rates for treatment goals and cardiovascular events (CVE) in ADPKD and their relations with asymptomatic CVD in CKD from other etiologies (CKDoe) and controls.Methods: We evaluated 2445 CKD patients (2010–2012). The information collected was: clinical, anthropometric and analytical parameters, treatments and CVD evaluation (intima-media thickness (IMT), atheromatous plaque presence and ankle-brachial index (ABI)). Laboratory, vital status, CVE and hospitalizations were collected for 4 years.Results: ADPKD patients had a worse renal function and worst achievement of blood pressure, higher parathormone levels but lower proteinuria compared to CKDoe. ADPKD patients presented lower IMT values than other groups, however, an intermediate rate of pathologic ABI and atheromatous plaque was present. More than half of the patients received statins, achieving LDL-c levels < 100 only in 50 and 39.8% of them (ADPKD and CKDoe respectively). The number of CVE during the follow-up period was low. In adjusted Cox regression model, ADPDK had the lowest occurrence of CVE of all three groups (HR:0.422, 95%CI 0.221–0.808,p = 0.009).Conclusion: ADPKD patients show intermediate control rates of CVD. A better control of CVD risk seems to be related with a lower load of CVD compared to other groups, which may lead in the long term to a better prognosis. Further investigation is necessary to determine cardiovascular prognosis in ADPKD.Keywords
This publication has 37 references indexed in Scilit:
- Predictors of Autosomal Dominant Polycystic Kidney Disease ProgressionJournal of the American Society of Nephrology, 2014
- Carotid artery Doppler ultrasonography in patients with chronic kidney diseaseMedical Science Monitor, 2014
- Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registryBMC Nephrology, 2013
- Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort studyBMC Nephrology, 2010
- Cardiovascular abnormalities in autosomal-dominant polycystic kidney diseaseNature Reviews Nephrology, 2009
- Carotid vascular remodelling in patients with autosomal dominant polycystic kidney diseaseNephrology, 2009
- Coronary Flow Velocity Reserve and Carotid Intima Media Thickness in Patients with Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortalityAmerican Journal of Kidney Diseases, 2001